喉癌患者治疗优先级的联合分析
本研究采用多机构调查的联合分析方法,纳入151例既往接受过治疗的喉癌患者,评估其对七个治疗属性的偏好。结果显示吞咽最为重要(25.7%±8.4%),其次为寿命(21.5%±9.3%)和癌症治愈(14.0%±6.4%)。接受挽救性手术的患者更重视癌症治愈。
要点
- 吞咽功能是喉癌患者最重视的治疗属性,平均重要性评分为25.7%。
- 寿命和癌症治愈分别位列第二和第三重要,评分分别为21.5%和14.0%。
- 接受挽救性手术的患者相比其他治疗组更看重癌症治愈(系数2.76,95%CI 0.33-5.19)。
核心结论
- 在既往接受过治疗的喉癌患者中,吞咽是最重要的治疗优先考虑因素,其次为寿命。
- 接受挽救性手术的患者在决策中更重视癌症治愈。
- 患者治疗偏好多样,可能在癌症治疗过程中发生变化,部分患者更重视生活质量而非寿命和癌症治愈。
研究设计与样本
- 多机构、基于调查的联合分析研究,聚焦七个属性:寿命、治疗类型、癌症治愈、自我形象、呼吸方式、发声和吞咽。
- 招募既往接受过治疗的喉癌患者(治疗完成超过6个月且无复发证据),共纳入151例。
主要发现
- 队列平均重要性评分(±标准差):吞咽25.7%(±8.4%)、寿命21.5%(±9.3%)、癌症治愈14.0%(±6.4%)、呼吸方式12.8%(±4.8%)、发声9.2%(±3.5%)、治疗类型9.1%(±5.0%)、自我形象7.7%(±4.4%)。
- 接受挽救性手术的患者相比其他治疗组更重视癌症治愈(系数2.76,95%CI 0.33-5.19)。
临床怎么用
- 临床决策应重视患者的吞咽功能保护,因其为患者最优先考虑的因素。
- 对于接受挽救性手术的患者,应加强关于癌症治愈的沟通。
- 需认识到患者偏好的多样性,个体化讨论生活质量与生存获益的平衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate patient priorities that may inform the choice of laryngeal cancer treatment. STUDY DESIGN: Multi-institutional, survey-based, conjoint analysis study focusing on seven attributes: lifespan, treatment type, cancer cure, self-image, mode of breathing, voicing, and swallowing. Patients with a history of treated laryngeal cancer (>6 months from treatment completion with no evidence of recurrent disease) were recruited. SETTING: Tertiary care medical centers. METHODS: Conjoint analysis yields utility scores, a quantitative measure of preference for an attribute. Higher utility scores indicate greater preference. Chi-squared, univariate logistic regression, and univariate linear regression analyses were used to evaluate associations between patient demographic and medical features with relative attribute preference. RESULTS: This study included 151 patients with previously treated laryngeal cancer. For the cohort, the mean importance scores (±standard deviation) were swallowing 25.7% (±8.4%), lifespan 21.5% (±9.3%), cancer cure 14.0% (±6.4%), mode of breathing 12.8% (±4.8%), voicing 9.2% (±3.5%), treatment type 9.1% (±5.0%), and self-image 7.7% (±4.4%). Patients who required salvage surgery after upfront chemoradiotherapy placed more value on cancer cure compared to the other treatment groups (coefficient 2.76, 95% CI 0.33-5.19). CONCLUSION: In patients with a history of treated laryngeal cancer, swallowing is the most important treatment priority, followed closely by lifespan. However, patients who underwent salvage surgery placed more value on cancer cure during decision-making. These findings demonstrate that patient treatment preferences are diverse and may change throughout the cancer care journey, with some patients placing a higher value on quality of life than lifespan and cancer cure.
引用
- Upton MK, Sridhar S, Dennison AM, et al. Treatment Priorities in Patients With a History of Laryngeal Cancer: A Conjoint Analysis. Otolaryngol Head Neck Surg. 2026. PMID: 42307983. doi:10.1002/ohn.70286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。